Global Cervical Screening Market Growth (Status and Outlook) 2024-2030

Global Cervical Screening Market Growth (Status and Outlook) 2024-2030

The global Cervical Screening market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Cervical Screening Industry Forecast” looks at past sales and reviews total world Cervical Screening sales in 2023, providing a comprehensive analysis by region and market sector of projected Cervical Screening sales for 2024 through 2030. With Cervical Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cervical Screening industry.

This Insight Report provides a comprehensive analysis of the global Cervical Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cervical Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cervical Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cervical Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cervical Screening.

Shift towards HPV Testing: Human Papillomavirus (HPV) testing has gained prominence as an effective method for cervical cancer screening. HPV testing is often used in conjunction with or as a replacement for Pap smears due to its higher sensitivity in detecting high-risk HPV strains associated with cervical cancer.

Liquid-Based Cytology: Liquid-based cytology (LBC) has become increasingly popular as an alternative to conventional Pap smears. LBC involves collecting cervical cells in a liquid medium, which can improve sample quality, reduce inadequate samples, and allow for additional testing such as HPV testing or molecular testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Cervical Screening market by product type, application, key players and key regions and countries.

Segmentation by type
Pap Test
HPV Test

Segmentation by application
Hospital
Diagnostic Laboratory
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott Laboratories
Hologic
Qiagen
Bio-Rad
BD
Quest Diagnostics
Hybribio
KingMed Diagnostics
Guangdong Hybribio Biotech
Dian Diagnostics
Shanghai ZJ Bio-Tech
Sansure Biotech
Jiangsu Bioperfectus Technologies
Triplex International Biosciences
ACON Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.